Work

Open‐Label Randomized Controlled Study of a Disposable Dry Seal Chest Drainage System for Safety and Efficiency in Lobectomy Patients

Year: 2026

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Abstract: BACKGROUND: Lobectomy, a cornerstone in the treatment of various thoracic tumors, often requires postoperative chest drainage to prevent complications such as pneumothorax and pleural effusion. Traditional water-seal drainage systems have limitations, including inconvenience and restricted patient mobility. METHODS: This study investigated the safety and efficiency of a disposable dry seal chest drainage system compared to the traditional water-seal system in lobectomy patients. An open-label randomized controlled trial with trial registration number NCTO6410716 was conducted, including 82 patients undergoing elective three-port thoracoscopic lobectomy. The study assessed postoperative pain, functional recovery, complications such as DVT, and nursing workload. RESULTS: The results showed that the disposable dry seal chest drainage system significantly reduced nursing workload (p < 0.001) and improved patient mobility, with patients in the experimental group having significantly higher finger oxygen saturation levels on postoperative day 1 (p = 0.01) and day 2 (p < 0.001) compared to the control group. The incidence of DVT during the hospital stay was also lower in the experimental group (p = 0.032). Although no significant improvement in postoperative pain scores was observed, the improved functionality and reduced nursing workload suggest potential benefits for patient care and resource management. CONCLUSIONS: This study provides valuable insights into the potential advantages of the new drainage system and its alignment with enhanced recovery after surgery (ERAS) protocols, supporting its use as a superior option in postoperative chest drainage management for lobectomy patients.

Source: Thoracic Cancer

DOI: 10.1111/1759-7714.70212